Skip to main navigation Skip to search Skip to main content

Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial

  • Byoung Chul Cho
  • , Dong Wan Kim
  • , Alexander I. Spira
  • , Jorge E. Gomez
  • , Eric B. Haura
  • , Sang We Kim
  • , Rachel E. Sanborn
  • , Eun Kyung Cho
  • , Ki Hyeong Lee
  • , Anna Minchom
  • , Jong Seok Lee
  • , Ji Youn Han
  • , Misako Nagasaka
  • , Joshua K. Sabari
  • , Sai Hong Ignatius Ou
  • , Patricia Lorenzini
  • , Joshua M. Bauml
  • , Joshua C. Curtin
  • , Amy Roshak
  • , Grace Gao
    • John Xie, Meena Thayu, Roland E. Knoblauch, Keunchil Park

Research output: Contribution to journal › Article › peer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science